Literature DB >> 16106051

Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines.

Yuwei Wang1, Arthur H Moser, Judy K Shigenaga, Carl Grunfeld, Kenneth R Feingold.   

Abstract

The acute-phase response (APR) suppresses type II nuclear hormone receptors and alters the expression of their target genes involved in lipid metabolism in the liver and heart. Therefore, we examined the expression of liver X receptor/retinoid X receptor (LXR/RXR) and their target genes in kidney from mice treated with lipopolysaccharide (LPS) and in human proximal tubular HK-2 cells treated with interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha). We found that LXRalpha and RXRalpha expression was suppressed by LPS in kidney and by IL-1beta or TNF-alpha in HK-2 cells. The decrease in LXRalpha/RXRalpha expression was associated with a decrease in the expression of several LXRalpha target genes [apolipoprotein E (apoE), ABCA1, ABCG1, and sterol-regulatory element binding protein-1c (SREBP-1c)] and a decrease in ligand-induced apoE expression. Moreover, IL-1beta and TNF-alpha significantly reduced liver X receptor response element (LXRE)-driven transcription as measured by LXRE-linked luciferase activity. However, overexpression of LXRalpha/RXRalpha only partially restored the cytokine-mediated reduction in LXRE-linked luciferase activity. Additionally, expression of the LXR coactivators peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC1alpha) and steroid receptor coactivator-2 (SRC-2) was decreased by IL-1beta or TNF-alpha. We conclude that the APR suppresses the expression of both nuclear receptors LXRalpha/RXRalpha and several LXRalpha coactivators in kidney, which could be a mechanism for coordinately regulating the expression of multiple LXR target genes that play important roles in lipid metabolism in kidney during the APR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106051     DOI: 10.1194/jlr.M500134-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

1.  Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.

Authors:  Monika Patel; Xiaoxin X Wang; Lilia Magomedova; Rohan John; Adil Rasheed; Hannah Santamaria; Weidong Wang; Ricky Tsai; Liru Qiu; Arturo Orellana; Andrew Advani; Moshe Levi; Carolyn L Cummins
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

2.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice.

Authors:  Mei Tran; Denise Tam; Amit Bardia; Manoj Bhasin; Glenn C Rowe; Ajay Kher; Zsuzsanna K Zsengeller; M Reza Akhavan-Sharif; Eliyahu V Khankin; Magali Saintgeniez; Sascha David; Deborah Burstein; S Ananth Karumanchi; Isaac E Stillman; Zoltan Arany; Samir M Parikh
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

3.  Vitamin A deficiency results in dysregulation of lipid efflux pathway in rat kidney.

Authors:  Haiping Yang; Ke Chen; Xuan Zhang; Li Wang; Cuicui Li; Hong Tao; Lijia Wang; Qiu Li
Journal:  Pediatr Nephrol       Date:  2010-05-18       Impact factor: 3.714

4.  ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Authors:  Kai Yin; Duan-fang Liao; Chao-ke Tang
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

Review 5.  Steroid receptor coactivators: servants and masters for control of systems metabolism.

Authors:  Erin Stashi; Brian York; Bert W O'Malley
Journal:  Trends Endocrinol Metab       Date:  2014-06-19       Impact factor: 12.015

6.  The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Reinhard Spanel; Florian Länger; Hyoung-Yun Han; Eun-Hee Lee; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-09-23

7.  Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia.

Authors:  Urmila Maitra; Samantha Chang; Neeraj Singh; Liwu Li
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407

8.  Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.

Authors:  Jingzhong Ding; Lindsay M Reynolds; Tanja Zeller; Christian Müller; Kurt Lohman; Barbara J Nicklas; Stephen B Kritchevsky; Zhiqing Huang; Alberto de la Fuente; Nicola Soranzo; Robert E Settlage; Chia-Chi Chuang; Timothy Howard; Ning Xu; Mark O Goodarzi; Y-D Ida Chen; Jerome I Rotter; David S Siscovick; John S Parks; Susan Murphy; David R Jacobs; Wendy Post; Russell P Tracy; Philipp S Wild; Stefan Blankenberg; Ina Hoeschele; David Herrington; Charles E McCall; Yongmei Liu
Journal:  Diabetes       Date:  2015-07-07       Impact factor: 9.461

Review 9.  The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.

Authors:  Qingguang Jiang; Michael Heneka; Gary E Landreth
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.

Authors:  Concetta Crisafulli; Emanuela Mazzon; Irene Paterniti; Maria Galuppo; Placido Bramanti; Salvatore Cuzzocrea
Journal:  Respir Res       Date:  2010-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.